OTC · Medical - Care Facilities

China Evergrande New Energy Vehicle Group Limited (EVGRF) Stock

$0.00 OTC: EVGRF Healthcare

China Evergrande New Energy Vehicle Group Limited, an investment holding entity, conducts its diverse business operations across the People's Republic of China, Europe, and on an international scale. The enterprise is strategically structured into two main divisions: Health Management and New Energy Vehicle.

Valuation

MetricValue
Price$0.00
Market Cap$2.17M
P/E Ratio-0.13
P/B Ratio-0.04
P/S Ratio0.00
EPS (TTM)$-1.10
52-Week High$0.10
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE31.70%
ROA-34.24%
ROCE39.71%
Gross Margin-668.81%
Operating Margin-668.81%
Net Margin-890.60%
Debt/Equity-0.71
Current Ratio0.34

Annual Financials (USD)

Metric20192020202120222023
Revenue$6.4B$15.5B$2.5B$134.0M$1.3B
Operating Profit$-2.2B$-4.6B$-53.2B$-12.1B$-9.0B
Net Profit$-5.0B$-7.4B$-56.3B$-27.7B$-11.9B
EPS$-0.58$-0.85$-5.85$-1.37$-1.10
Op Margin-33.7%-29.8%-2101.1%-9060.0%-668.7%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$104.5B$177.9B$175.6B$129.4B$34.9B
Total Liabilities$105.9B$184.8B$223.7B$206.4B$72.5B
Cash$13.7B$16.8B$6.4B$269.0M$129.0M
Borrowings$70.3B$73.0B$41.7B$26.6B$26.8B

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-15.4B$-631.0M$9.3B$-2.4B$-251.0M
Investing Cash Flow$-25.6B$-21.5B$-16.7B$-3.6B$-1.7B
Financing Cash Flow$5.2B$-3.8B$-431.0M$-279.0M$-24.0M
Net Cash Flow$11.5B$618.0M$-8.0B$-2.2B$-580.0M
Free Cash Flow$-23.4B$-13.0B$-1.1B$-4.9B$-1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.58
FCF Yield-90.69%
Quick Ratio0.33
Interest Coverage-4.66
Return 1Y-98.18%
Return 3Y0.00%
Return 5Y

Ownership

Insiders Held58.01%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AONCAmerican Oncology Network, Inc. $12.00 +20.00% -17.39 $350.98M 0.00%
BHCCFBenchmark Holdings plc $0.37 +0.00% -4.13 $225.11M 0.00%
MAYNFMayne Pharma Group Limited $1.97 +0.00% -2.55 $160.30M 0.00%
MFCSFMedical Facilities Corporation $12.63 -1.33% 8.79 $221.66M 1.98%
MKLNFM1 Kliniken AG $11.73 +0.00% 15.77 $214.81M 11.68%

About China Evergrande New Energy Vehicle Group Limited

China Evergrande New Energy Vehicle Group Limited, an investment holding entity, conducts its diverse business operations across the People's Republic of China, Europe, and on an international scale. The enterprise is strategically structured into two main divisions: Health Management and New Energy Vehicle. Under its Health Management segment, the company is involved in the creation and sale of health-focused living properties. It also delivers a range of services, including comprehensive community health programs, advanced medical cosmetology, anti-aging therapies, and extensive elderly care and rehabilitation. Additionally, this division handles the wholesale distribution of home care and various healthcare products, offers healthcare services, and provides software solutions. Its scope further extends to pharmaceutical research and development, along with the production of medical equipment. The New Energy Vehicle division focuses on the research, development, manufacturing, and marketing of new energy vehicles, alongside related vehicle living initiatives. This segment also covers the production and sale of smart mobility products and lithium-ion batteries. Originally founded in 1999 as Evergrande Health Industry Group Limited, the company re-branded to China Evergrande New Energy Vehicle Group Limited in August 2020. Headquartered in Guangzhou, China, it operates as a subsidiary of the China Evergrande Group.

China Evergrande New Energy Vehicle Group Limited (EVGRF) stock trades at $0.00 with a market capitalization of $2.17M. The stock is valued at a price-to-earnings (P/E) ratio of -0.13, price-to-book of -0.04, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 100.0% below its 52-week high.

On profitability, China Evergrande New Energy Vehicle Group Limited generates a return on equity (ROE) of 31.70% — well above the market average, a sign of a high-quality business, return on capital employed of 39.71%, an operating margin of -668.81%, a net profit margin of -890.60%.

Official website: health.evergrande.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides